Alzinova Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 10

Employees

  • Stock Symbol
  • ALZ

Stock Symbol

  • Share Price
  • $0.03
  • (As of Friday Closing)

Alzinova General Information

Description

Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Erik Dahlbergsgatan 11 A
  • 411 26 Gothenburg
  • Sweden
+46 070-428
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
STO
Corporate Office
  • Erik Dahlbergsgatan 11 A
  • 411 26 Gothenburg
  • Sweden
+46 070-428

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alzinova Stock Performance

As of 13-Nov-2026, Alzinova’s stock price is $0.03. Its current market cap is $10M with 316M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.03 $0.03 $0.03 - $0.21 $10M 316M 2.46M -$0.02

Alzinova Financials Summary

As of 30-Jun-2026, Alzinova has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 9,173 9,362 25,516 10,231
Revenue 0 0 0 0
EBITDA (2,404) (2,606) (1,927) (1,554)
Net Income (2,598) (2,673) (1,943) (1,550)
Total Assets 16,834 15,587 12,075 12,326
Total Debt 0 87 73 80
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alzinova Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alzinova‘s full profile, request access.

Request a free trial

Alzinova Patents

Alzinova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024238598-A1 Humanised antibody against amyloid beta 42 Pending 20-Mar-2023
EP-4683940-A1 Humanised antibody against amyloid beta 42 Pending 20-Mar-2023
WO-2024194298-A1 Humanised antibody against amyloid beta 42 Inactive 20-Mar-2023
EP-2497782-A1 Anti oligomer antibodies and uses thereof Inactive 08-Mar-2011
EP-2683738-A1 Anti oligomer antibodies and uses thereof Active 08-Mar-2011 C07K16/18
To view Alzinova’s complete patent history, request access »

Alzinova Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alzinova Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alzinova‘s full profile, request access.

Request a free trial

Alzinova ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Alzinova’s complete esg history, request access »

Alzinova FAQs

  • When was Alzinova founded?

    Alzinova was founded in 2011.

  • Where is Alzinova headquartered?

    Alzinova is headquartered in Gothenburg, Sweden.

  • What is the size of Alzinova?

    Alzinova has 10 total employees.

  • What industry is Alzinova in?

    Alzinova’s primary industry is Drug Discovery.

  • Is Alzinova a private or public company?

    Alzinova is a Public company.

  • What is Alzinova’s stock symbol?

    The ticker symbol for Alzinova is ALZ.

  • What is the current stock price of Alzinova?

    As of 13-Nov-2026 the stock price of Alzinova is $0.03.

  • What is the current market cap of Alzinova?

    The current market capitalization of Alzinova is $10M.

  • What is Alzinova’s annual earnings per share (EPS)?

    Alzinova’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process